Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/22/2007US20070269528 A Omega-conopeptide, and the anitoxidant methionine, and either clonidine or baclofen; ziconotide retains its potency and is physically and chemically compatible with the analgesic; for intrathecal administration
11/22/2007US20070269527 Therapeutic agents for low HDL-cholesterolemia
11/22/2007US20070269526 Carotenoid Composition and Method for Preparation Thereof
11/22/2007US20070269525 O/W Gel Compositions Comprising Wax
11/22/2007US20070269524 Use of Idrocilamide for the Preparation of a Pharmaceutical Composition of Rosacea
11/22/2007US20070269516 Controlled release matrix
11/22/2007US20070269514 Tablet composition with a prolonged release of tamsulosin
11/22/2007US20070269513 Liver selective drug therapy
11/22/2007US20070269512 Gastroretentive sustained release formulations
11/22/2007US20070269511 Solid pharmaceutical compositions containing pregabalin
11/22/2007US20070269510 Solid Unit Dosage Forms of 5-Ht1 Agonist
11/22/2007US20070269509 Enteric Coated Pharmaceutical Oral Formulations Comprising Acid-Labile Active Substances, and a Method Thereof
11/22/2007US20070269507 Pharmaceutical Composition
11/22/2007US20070269506 Oral Sustained Release Pharmaceutical Composition
11/22/2007US20070269505 Tamper Resistant Co-Extruded Dosage Form Containing An Active Agent And An Adverse Agent And Process Of Making Same
11/22/2007US20070269504 Amphoteric liposomes
11/22/2007US20070269503 Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
11/22/2007US20070269502 Stable Liposome Compositions Comprising Lipophilic Amine Containing Pharmaceutical Agents
11/22/2007US20070269495 Compositions and methods for enhancing mineral levels in animals with reduced environmental impact
11/22/2007US20070269494 Compositions and methods for enhancing active agent absorption
11/22/2007US20070269490 Material for Processed Food for Weight Reduction Diets and Weight Reduction Dietary Processed Food Using Thereof
11/22/2007US20070269488 Hydrogel Nanocompsites for Ophthalmic Applications
11/22/2007US20070269487 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System
11/22/2007US20070269486 Methods and Devices for Reducing Tissue Damage After Ischemic Injury
11/22/2007US20070269484 Drug-delivery stent formulations for restenosis and vulnerable plaque
11/22/2007US20070269482 Implants for the treatment of dopamine associated states
11/22/2007US20070269481 microfiber or nanofiber polymer scaffolds, non-covalently associated or covalently attached to cell growth factors, used to promote the growth of new tissues or replace damaged tissues
11/22/2007US20070269477 Heart Treatment Method
11/22/2007US20070269470 Oil base and external preparation containing same
11/22/2007US20070269468 Fat Compositions
11/22/2007US20070269465 Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine
11/22/2007US20070269454 Composition for External Use
11/22/2007US20070269448 Transition State Analog Inhibitors Of Ricin A-Chain
11/22/2007US20070269432 Method of Diagnosing Breast Cancer
11/22/2007US20070269430 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
11/22/2007US20070269423 kit comprises a nucleic acid, use for detection and treatment of human cancers by inhibiting the enzyme activities; biodrug as anticarcinogenic agents
11/22/2007US20070269422 Serum albumin binding proteins with long half-lives
11/22/2007US20070269421 Diagnostics and Therapeutics for Diseases Associated with Plasma Glutamate Carboxypeptidase (Pgcp)
11/22/2007US20070269420 Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases
11/22/2007US20070269419 Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
11/22/2007US20070269417 Nicotine delivery systems
11/22/2007US20070269407 Use of interleukin-19 to treat cervical cancer
11/22/2007US20070269405 Androgen Receptor Modulators
11/22/2007US20070269403 Composition and method for treatment of hepatic encephalopathy
11/22/2007US20070269395 Inhibition of hairless protein mRNA
11/22/2007US20070269393 Topical anesthetic formulation
11/22/2007US20070269389 Base Composition for Preparing Multi-Functional Formulations for Care and Protection of the Skin and Hair
11/22/2007US20070269387 Moisture-Retaining Agent Comprising Alpha-Glycosyl Glycyrrhizing As An Effective Ingredient And Use Thereof
11/22/2007US20070269386 New product and use and manufacture thereof
11/22/2007US20070269385 Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders
11/22/2007US20070269380 Methotrexate-modified nanoparticles and related methods
11/22/2007US20070269379 Penetration Enhancer Combinations for Transdermal Delivery
11/22/2007US20070269375 Stable Radiopharmaceutical Compositions and Methods for Preparation
11/22/2007US20070269374 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
11/22/2007US20070269373 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo.
11/22/2007US20070269368 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
11/22/2007DE20321531U1 Lagerstabiles pharmazeutisches Präparat, das Oxycodon und Naloxon umfaßt A shelf-stable pharmaceutical preparation comprising oxycodone and naloxone
11/22/2007DE202004021399U1 Salz einer Sulfonsäure mit Clopidogrel und dessen Verwendung zur Herstellung pharmazeutischer Formulierungen Salt of a sulfonic acid with clopidogrel and its use for the preparation of pharmaceutical formulations
11/22/2007DE10297577B4 Zinkkomplexe, die fähig sind, Substanzen, die anionische Substituenten haben, abzufangen Zinc complexes, which are capable of substances having anionic substituents trap,
11/22/2007DE102007021043A1 Alpha-Form von Imatinib Mesylat und Verfahren zu seiner Herstellung Alpha-form of imatinib mesylate and a process for its preparation
11/22/2007DE102006023770A1 Treibgasfreie Aerosolformulierung für die Inhalation Propellant-free aerosol formulation for inhalation
11/22/2007DE102006023337A1 Triazolderivate II Triazole derivatives II
11/22/2007DE102006023336A1 1,5-Diphenyl-pyrazole II 1,5-diphenyl-pyrazoles II
11/22/2007DE102006023242A1 5-Iodtetrazole zur Verwendung als Antimykotika 5-iodotetrazoles for use as antifungal agents
11/22/2007DE102006022908A1 Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten Use of quinolone derivatives as antiprotozoäre agent and in combination preparations
11/22/2007DE102006021874A1 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, process for their preparation and their use as medicaments
11/22/2007DE102006021733A1 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung 3 Tetrazolylindazole and 3-Tetrazolylpyrazolopyridine and their use
11/22/2007DE102005014080B4 Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel Addition salts of tolperisone, processes for their manufacture, use thereof and pharmaceutical compositions containing them
11/22/2007CA2694955A1 3,4-disubstituted coumarin and quinolone compounds
11/22/2007CA2654492A1 Treprostinil administration using a metered dose inhaler
11/22/2007CA2653753A1 Substituted prolinamides, production thereof and their use as medicaments
11/22/2007CA2653244A1 Imaging agents and methods
11/22/2007CA2652866A1 Therapeutic compounds
11/22/2007CA2652705A1 Dioxaspiroketal derivatives, process for their preparation and uses thereof
11/22/2007CA2652610A1 Nicotinic acetylcholine receptor ligands 101
11/22/2007CA2652500A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007CA2652499A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent
11/22/2007CA2652483A1 Use of drospirenone for preventing high blood pressure in prehypertensive patients
11/22/2007CA2652455A1 Iap bir domain binding compounds
11/22/2007CA2652349A1 Toll-like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration
11/22/2007CA2652347A1 Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
11/22/2007CA2652345A1 Methods and compositions for treatment of sleep apnea related applications
11/22/2007CA2652343A1 Nf-kb inhibitors and uses thereof
11/22/2007CA2652339A1 Cdki pathway inhibitors as selective inhibitors of tumor cell growth
11/22/2007CA2652328A1 Prophylactic and therapeutic agent for cancer
11/22/2007CA2652300A1 Pharmaceutical formulations of pimavanserin
11/22/2007CA2652274A1 Il-1.alpha. immunization induces autoantibodies protective against atherosclerosis
11/22/2007CA2652263A1 Therapeutic compounds and their use in cancer
11/22/2007CA2652235A1 Methods for treating blood disorders
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/22/2007CA2652072A1 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/22/2007CA2652057A1 Medication against breast cancer and related diseases
11/22/2007CA2652035A1 Anticancer treatments
11/22/2007CA2652023A1 New form of administration of racecadotril
11/22/2007CA2652015A1 Methods and compositions for treating and preventing peripheral nerve damage
11/22/2007CA2652008A1 A process for the preparation of a taxane derivative
11/22/2007CA2651983A1 Modified chalcone compounds as antimitotic agents
11/22/2007CA2651968A1 1h-indol-5-yl-piperazin-1-yl-methanone derivatives
11/22/2007CA2651933A1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
11/22/2007CA2651871A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
1 ... 3492 3493 3494 3495 3496 3497 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 3511 3512 ... 7860